The FDA has expanded the indication of Incyte’s Opzelura (ruxolitinib) cream to include children aged two to 11 years with ...
Advanced Provides Clarity in 3D Heartflow Plaque Analysis is the only FDA-cleared, AI-powered plaque quantification tool with a reported 95% agreement with the gold standard, IVUS, using blinded core ...
Bayer announced today that data from across the KERENDIA ® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific ...
Susvimo is under review with the EMA and once approved will be the first continuous delivery treatment for nAMD, affecting 1,7 million in the European Union1 New seven-year data from the LADDER study ...
Wegovy (semaglutide) pens should generally be stored in the refrigerator to maintain their effectiveness. If refrigeration isn’t possible, Wegovy can be kept out of the refrigerator for up to 28 days ...
Oral semaglutide (Rybelsus ®) is now the first and only oral GLP-1 RA approved for type 2 diabetes, with proven cardiovascular benefits 1; This approval is based on results from ...
The FDA approves Forzinity (elamipretide HCl) to improve muscle strength in adult and pediatric patients with Barth syndrome weighing at least 30kg.
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study ...
People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-beingResults from a real-world survey suggest that semaglutide for weight management (Wegovy®) helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback